Polymorphisms in the CPB2 Gene Are Maintained by Balancing Selection and Result in Haplotype-Preferential Splicing of Exon 7

Diverse Evolutionary Histories for β-adrenoreceptor Genes in Humans

(2009) Rachele Cagliani et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Thrombin-activatable fibrinolysis inhibitor-a inhibitors: Drugs for sepsis or drugs for disseminated intravascular coagulation?*

(2009) Carl-Erik Dempfle et al.   CRITICAL CARE MEDICINE

EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats*

(2009) Yuko Muto et al.   CRITICAL CARE MEDICINE

Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients

(2008) Arijit Biswas et al.   ANNALS OF HEMATOLOGY

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation

(2008) P. F. Marx et al.   BLOOD

The Roles of Selected Arginine and Lysine Residues of TAFI (Pro-CPU) in Its Activation to TAFIa by the Thrombin-Thrombomodulin Complex

(2008) Chengliang Wu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Overdominance in the Human Genome and Olfactory Receptor Activity

(2008) S. Alonso et al.   MOLECULAR BIOLOGY AND EVOLUTION

Structure of Activated Thrombin-Activatable Fibrinolysis Inhibitor, a Molecular Link between Coagulation and Fibrinolysis

(2008) Laura Sanglas et al.   MOLECULAR CELL

Biochemical Importance of Glycosylation in Thrombin Activatable Fibrinolysis Inhibitor

(2007) Karlien Buelens et al.   CIRCULATION RESEARCH